Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06620900

Expanding Access to mTBI Treatment for Veterans and Service Members With Co-occurring Substance Use

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
360 (estimated)
Sponsor
Shepherd Center, Atlanta GA · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research is to determine whether military veterans and service members with mild traumatic brain injury with and without co-occurring substance use can complete and benefit from integrated interdisciplinary care individualized to their symptoms, goals, and needs. Participants will complete surveys about substance use and other symptoms at the beginning and end of treatment in an intensive outpatient program and 6 months after discharge.

Detailed description

This pragmatic clinical trial will (1) assess treatment retention and treatment outcomes at the completion of interdisciplinary intensive outpatient program (IOP) and at a 6-month follow-up comparing service members and veterans (SM/Vs) with mild traumatic brain injury (mTBI) + substance use (SU) and a TBI -control group; and (2) assess SU-related outcomes at the end of IOP treatment and durability of SU outcomes at 6-months follow-up among SM/Vs with co-occurring SU. Analyses of these key treatment outcomes along with input from lived experience consultants and other key stakeholders, will be used to refine and disseminate a scalable approach to treating individuals with mTBI and co-occurring SU.

Conditions

Interventions

TypeNameDescription
OTHERIntegrated Model of CareThe Integrated Model of Care was developed and piloted by the study team provide support for individuals seeking care in an interdisciplinary intensive outpatient program for mild traumatic brain injury to receive support for co-occurring substance use-related needs.

Timeline

Start date
2025-02-01
Primary completion
2028-08-01
Completion
2028-08-01
First posted
2024-10-01
Last updated
2024-10-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06620900. Inclusion in this directory is not an endorsement.